These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25550892)

  • 1. Stem cell-based therapies for age-related macular degeneration: current status and prospects.
    Mu Y; Zhao M; Su G
    Int J Clin Exp Med; 2014; 7(11):3843-52. PubMed ID: 25550892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell therapies for age-related macular degeneration: the past, present, and future.
    Dang Y; Zhang C; Zhu Y
    Clin Interv Aging; 2015; 10():255-64. PubMed ID: 25609937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell based therapies for age-related macular degeneration: The promises and the challenges.
    Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS
    Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human-induced pluripotent stem cells-derived retinal pigmented epithelium, a new horizon for cells-based therapies for age-related macular degeneration.
    Dehghan S; Mirshahi R; Shoae-Hassani A; Naseripour M
    Stem Cell Res Ther; 2022 May; 13(1):217. PubMed ID: 35619143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem Cell-Based Therapy for Diseases of the Retinal Pigment Epithelium: From Bench to Bedside.
    Sachdeva MM; Eliott D
    Semin Ophthalmol; 2016; 31(1-2):25-9. PubMed ID: 26959126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell-derived retinal pigment epithelium transplantation in age-related macular degeneration: recent advances and challenges.
    Kashani AH
    Curr Opin Ophthalmol; 2022 May; 33(3):211-218. PubMed ID: 35200164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Novel approach for management of age-related macular degeneration--antiangiogenic therapy and retinal regenerative therapy].
    Tamaki Y
    Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):232-68; discussion 269. PubMed ID: 17402564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of the RPE in AMD.
    Binder S; Stanzel BV; Krebs I; Glittenberg C
    Prog Retin Eye Res; 2007 Sep; 26(5):516-54. PubMed ID: 17532250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dry Age-Related Macular Degeneration Pharmacology.
    Wright CB; Ambati J
    Handb Exp Pharmacol; 2017; 242():321-336. PubMed ID: 27900609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the management of dry age-related macular degeneration: A review.
    Bandello F; Sacconi R; Querques L; Corbelli E; Cicinelli MV; Querques G
    F1000Res; 2017; 6():245. PubMed ID: 28529701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stemming retinal regeneration with pluripotent stem cells.
    Jin ZB; Gao ML; Deng WL; Wu KC; Sugita S; Mandai M; Takahashi M
    Prog Retin Eye Res; 2019 Mar; 69():38-56. PubMed ID: 30419340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of Transplantable Retinal Pigmented Epithelial (RPE) Cells for Treatment of Age-Related Macular Degeneration (AMD).
    Surendran H; Rathod RJ; Pal R
    Methods Mol Biol; 2019; 2045():283-298. PubMed ID: 29896658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced pluripotent stem cell-based therapy for age-related macular degeneration.
    Bracha P; Moore NA; Ciulla TA
    Expert Opin Biol Ther; 2017 Sep; 17(9):1113-1126. PubMed ID: 28664762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of Induced Pluripotent Stem Cells (iPSCs) for Treating Age-Related Macular Degeneration (AMD).
    Fields M; Cai H; Gong J; Del Priore L
    Cells; 2016 Dec; 5(4):. PubMed ID: 27941641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of RPE in age-related macular degeneration: observations in disciform lesions and dry RPE atrophy.
    Algvere PV; Berglin L; Gouras P; Sheng Y; Kopp ED
    Graefes Arch Clin Exp Ophthalmol; 1997 Mar; 235(3):149-58. PubMed ID: 9085110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Refined Protocol for Trans-scleral Subretinal Transplantation of Human Retinal Pigment Epithelial Cells into Rat Eyes.
    Zhao C; Boles NC; Miller JD; Kawola S; Temple S; Davis RJ; Stern JH
    J Vis Exp; 2017 Aug; (126):. PubMed ID: 28829422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem Cell Therapy in Nonneovascular Age-Related Macular Degeneration.
    Kashani AH
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(5):ORSFm1-9. PubMed ID: 27116669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer "cell therapy" clinics.
    Hinkle JW; Mahmoudzadeh R; Kuriyan AE
    Stem Cell Res Ther; 2021 Oct; 12(1):538. PubMed ID: 34635174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence of retinal pigment epithelial changes after macular translocation with 360 degrees peripheral retinectomy for geographic atrophy.
    Cahill MT; Mruthyunjaya P; Bowes Rickman C; Toth CA
    Arch Ophthalmol; 2005 Jul; 123(7):935-8. PubMed ID: 16009834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal pigment epithelium differentiation of stem cells: current status and challenges.
    Uygun BE; Sharma N; Yarmush M
    Crit Rev Biomed Eng; 2009; 37(4-5):355-75. PubMed ID: 20528731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.